Dark

Search

REVB
Revelation Biosciences Inc
stock NASDAQ

At Close

3/24/2023 3:59:46 PM EDT

1.51USD+10.219%(+0.14)254,244

1.49Bid 1.54Ask 0.05Spread IEX

Pre-market

3/24/2023 9:22:30 AM EDT

1.41USD+2.920%(+0.04)195

After-hours

3/24/2023 4:00:30 PM EDT

1.48USD-1.987%(-0.03)0

Overview HistoricalNews

Jan 24, 2022

08:06AM EST Revelation Biosciences Raises $7.76M In Equity Financing Benzinga

08:00AM EST Revelation Biosciences Raises $7.76 Million in Equity Financing GlobeNewswire Inc

Jan 20, 2022

09:07AM EST Revelation Biosciences Inc. Announces First Group Of Patients Dosed In Phase 2b Viral Challenge Study To Assess Efficacy Of Intranasal REVTx-99 For The Prevention Of H3N2 Influenza Infection Benzinga

09:00AM EST Revelation Biosciences Inc. Announces First Group of Patients GlobeNewswire Inc

Jan 18, 2022

09:07AM EST Revelation Biosciences Announces First Patient Enrolled, Dosed In Phase 1b Clinical Study Of REVTx-99 For Treatment Of Allergic Rhinitis Benzinga

09:00AM EST Revelation Biosciences Inc. Announces First Patient Enrolled and GlobeNewswire Inc

Jan 13, 2022

01:55PM EST -A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- GlobeNewswire Inc

Jan 11, 2022

09:05AM EST EXCLUSIVE: Revelation Biosciences Says 'REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems' Benzinga

09:05AM EST EXCLUSIVE: Revelation Biosciences Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2 Benzinga

09:05AM EST EXCLUSIVE: Revelation Biosciences Says 'A greater than 50% reduction in SARS-CoV-2 Delta viral was observed' Benzinga

09:00AM EST -A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- GlobeNewswire Inc

08:55AM EST EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Says 'A greater than 50% reduction in SARS-CoV-2 Delta viral was observed' Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Says 'REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems' Benzinga

08:55AM EST EXCLUSIVE: Revelation Biosciences Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2 Benzinga

08:01AM EST New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action Benzinga

Feb 10, 2021

12:48PM EST How Is OTC Markets Different From Exchanges? Benzinga

Share